Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study
Carcinoma, Renal Cell
Molecular Targeted Therapy
We report the largest retrospective cohort of patients with mChRCC treated with TT and no significant difference between AA and mTOR inhibitors was observed for TTF and OS.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency